Labiotech.eu

roche immuno oncology blueprint medicines boston

News and Trends 18 Mar 2016

Roche signs a €900M deal with an Immunotherapy Biotech in Boston

Roche (Switzerland) has picked 5 candidates from Blueprint Medicines (US) to complement its leading oncology pipeline. Roche is a leader in cancer therapies, but its position is threatened by intense competition, not to mention its stakes in the biosimilar war and some bad results from advanced trials. However, it seems that this Big Pharma still […]

March 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 18 Mar 2016

Biotech of the Week: Addex Therapeutics, a Swiss Biotech on a Rollercoaster ride

This week we wave goodbye to the United Kingdom and all its glory and through the English channel, we head south to charming Switzerland. Geneva is our destination and it is where Addex Therapeutics, our Biotech of the Week, is based. City: Geneva (Switzerland) Founded: 2002 Employees: 5 Market Capitalization: €30M (3/2016) CEO: Tim Dyer Mission: Founded in […]

March 18, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 17 Mar 2016

“We have Reshaped how Innovation occurs inside Pierre Fabre”

This is what Laurent Audoly, Head of R&D of Pierre Fabre, told me at the SACHS conference in Zurich last Tuesday. The French Big Pharma recently opened its fund for innovation and it was a great opportunity to get a better insight into it. Pierre Fabre is the 3rd largest Pharma in France, counting over […]

March 17, 2016 - 1 minutemin - By Philip Hemme

gecko surgical adhesive sofinnova bpifrance

News and Trends 17 Mar 2016

Leading European VC believes this is the “Post-It of Surgery”

Gecko Biomedical (France) has raised €22.5M to get its innovate biopolymers to surgery rooms, and caught the eye of the biggest French Biotech investor, Sofinnova. Gecko has a hot piece of MedTech in its hands: a surgical glue that can stop bleeding from sutured tissues, and in the future could replace stitching altogether. This technology was […]

March 17, 2016 - 3 minutesmins - By Denise Neves Gameiro

gsk miltenyi biotech gmp cell gene therapy tcr car t

News and Trends 17 Mar 2016

GSK partners to Scale Manufacturing of CAR-T Therapies

Production of CAR-T therapies seems to be one of the biggest challenge of this promising technology. Miltenyi Biotec (Germany) and GSK have entered a new partnership to combine the clinical development of cell and gene therapies with manufacturing expertise. Milteniy is a German company of 1600 employees developing products for biomedical research and cellular therapy. It’s not the first […]

March 17, 2016 - 3 minutesmins - By Denise Neves Gameiro

migraine biotech cgrps heptares review neurology

News and Trends 17 Mar 2016

A Relief for Migraines at last? The Biotech race for the Ultimate Cure

A Migraine is more than just a headache; it is a neurological disorder affecting a staggering 10% of the worldwide population. So where are we on fighting a viable therapy – and who is working on Migraines? People of all ages are at risk of migraine, with women being three times more likely to suffer from […]

March 17, 2016 - 4 minutesmins - By Ekaterina Perets

bionic heart patch university tel aviv tau biomaterial nanoelectronics tissue engineering myocardial infarction heart attack nature materials

News and Trends 16 Mar 2016

‘Cyborg’ Heart Patch to Revolutionize Treatment of Heart Attacks

Researchers from Tel Aviv University (Israel) have managed to engineer a Nanotech ‘heart patch’ which could enable remote monitoring and regulation of a patient’s heart – bionic! MedTech continues to blur the boundary between man and machine. A new project combines organic, living tissue and a complex nanoelectronic system to create a bionic heart patch that could help […]

March 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

cellectis ucart leukemia cancer gmp manufacturing ucart19 ucart123 allogeneic universal 2015 financial results

News and Trends 16 Mar 2016

How Good was 2015 for the French Universal CAR-T Biotech?

Cellectis (France) has now released its financial results for 2015. What happened and what the prospects for 2016 and long-term? It was a really packed year for Cellectis, the French Champion for universal, off-the-shelf CAR-T treatments. The Biopharma saw significant advances in multiple fronts, from clinical development to financing. The first therapy initially developed by […]

March 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

mission therapeutics sachs interview zurich labiotech biotech

News and Trends 16 Mar 2016

Interviewing the Biotech which raised the Biggest European Round in 2016 so far

Yesterday I flew to Switzerland for the day, to gage what was going on at the 9th Annual Sachs conference for European Biotech CEOs. Here I had the chance to Interview Cambridge UK’s Mission Therapeutics on investment and technology.. Panel discussions covered Partnering and Investment for various therapeutic platforms – in MedTech, Diagnostics and generally ‘Israel’ (and […]

March 16, 2016 - 1 minutemin - By Philip Hemme

deinove deinococci biorefinery green chemistry arbiom biomass wood pretreatment lignin optafuel biomethodes bioskog

News and Trends 15 Mar 2016

French SynBio Biotech to ferment wood for Carbon-free Future

Deinove (Montpelier) and Arbiom (Evry) are two Biotechs from France which have now partnered to transform wood residues into added-value chemicals – a step closer to the ideal Bioeconomy. Deinove is one of our favourite Green Chemistry and SynBio Biotechs, developing micro-factories with their library of Deinococcus. Its projects range from using tobacco plants to making carotenoids, also with […]

March 15, 2016 - 3 minutesmins - By Denise Neves Gameiro

nanobiotix private placement €21M nanoxray sarcoma liver head neck prostate cancer nbtxr3 nanomedicine radiotherapy localized

News and Trends 15 Mar 2016

French Nanomedicine Biotech Gets €21M to Kill Cancer with ‘Beam Rays’

Nanobiotix (France) has had a successful private placement in, raising €21.3M to advance the clinical development of its localised radiotherapy for Cancer. Located in Paris’ superbiocluster, Nanobiotix wants to change the way cancer is treated – but in a different way from most Biotech strategies. It is developing NanoXRay, a paradigm-shifting nanotechnology for localised radiotherapy. Nanobiotix has […]

March 15, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 15 Mar 2016

How will the UK’s Potential Exit from the EU Affect the Biotech Industry?

I’m a UK Expat in Berlin, and whilst I admit confusion over where exactly the British Exit (i.e. “Brexit”) will leave me in the future, in general it is a depressing thought – for the UK Biotech Industry also. What exactly are the Industry logistics for the UK detaching itself from the EU? Admittedly there […]

March 15, 2016 - 6 minutesmins - By Dani Bancroft

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Roche signs a €900M deal with an Immunotherapy Biotech in Boston

Biotech of the Week: Addex Therapeutics, a Swiss Biotech on a Rollercoaster ride

“We have Reshaped how Innovation occurs inside Pierre Fabre”

Leading European VC believes this is the “Post-It of Surgery”

GSK partners to Scale Manufacturing of CAR-T Therapies

A Relief for Migraines at last? The Biotech race for the Ultimate Cure

‘Cyborg’ Heart Patch to Revolutionize Treatment of Heart Attacks

How Good was 2015 for the French Universal CAR-T Biotech?

Interviewing the Biotech which raised the Biggest European Round in 2016 so far

French SynBio Biotech to ferment wood for Carbon-free Future

French Nanomedicine Biotech Gets €21M to Kill Cancer with ‘Beam Rays’

How will the UK’s Potential Exit from the EU Affect the Biotech Industry?

Subscribe to our newsletter to get the latest biotech news!